Lotus Pharmaceutical Placement - Sound Fundamentals but Doesn’t Seem Well Flagged
Lotus Pharmaceutical (1795 TT)'s majority shareholder, Alvogen Emerging Markets Holdings (AEMH), aims to raise up to US$247m through an affiliated...
547 Views
No more insights